Skip to content

To study the effects of homoeopathic treatment in reduction of smokeless tobacco.

Effects of individualized homoeopathic treatment in reduction of dependency in smokeless tobacco users assessed by Fagerstorm nicotine dependence scale - smokeless tobacco (FTND-ST)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054183
Enrollment
10
Registered
2023-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F172- Nicotine dependence

Interventions

Intervention1: Individualized Homoeopathic Medicines: 2 pills (OD) for 2 days, Oral route administration followed with Rubrum 2 pills (BD) for 1 month. Control Intervention1: Nil: Nil

Sponsors

Noble Homoeopathic College and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. New cases diagnosed on the basis of diagnostic criteria and pre diagnosed cases of smokeless tobacco. 2. Patients willing to participate in the study and giving written informed consent. 3. Only those patients will be considering into the study that have consumption of smokeless tobacco for last 1 year or more. 4. Currently and continuous uses of smokeless tobacco.

Exclusion criteria

Exclusion criteria: 1. Cases with any type of oral pathology. 2. Patients with other systemic diseases. 3. Patients having mental and behaviour disorder due to psycho active substance other than tobacco. 4. Patient is already under going nicotine replacement therapy. 5. Patient already undergoing homoeopathic treatment for any chronic disease. 6. Any symptoms suggestive of any serious medical condition that may require active intervention within 6 months. 7. Pregnant women and lactating mothers. 8. Patients not giving written consent.

Design outcomes

Primary

MeasureTime frame
To assess changes in the FTND-ST through individualized homoeopathic treatment.Timepoint: Baseline, 4 weeks, 8 weeks, 12 weeks, till 6th month.

Secondary

MeasureTime frame
To shortlist the commonly indicated homoeopathic medicines.Timepoint: Baseline, 4 weeks, 8 weeks, 12 weeks, till 6th month.

Countries

India

Contacts

Public ContactSargam Ramesh Singh

Noble Homoeopathic College and Research Institute

dileep.verma@ngivbt.edu.in9415123100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026